Previous studies [36–38] have shown that patients with non-small cell lung cancer (NSCLC) had higher percentage of CD8+ Tregs than healthy controls and that this T-cell subset is correlated with pathological stage of NSCLC. Here, CD8A is linked to non-small cell lung carcinoma.